Last updated: 27 August 2024 at 7:09pm EST

Michael Amoroso Net Worth




The estimated Net Worth of Michael Amoroso is at least $1.2 Million dollars as of 1 May 2024. Mr Amoroso owns over 3,417 units of Precision BioSciences stock worth over $160,629 and over the last 4 years he sold DTIL stock worth over $161,736. In addition, he makes $876,238 as Pres and CEO & Director at Precision BioSciences.

Mr Amoroso DTIL stock SEC Form 4 insiders trading

Mr has made over 12 trades of the Precision BioSciences stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 3,417 units of DTIL stock worth $35,879 on 1 May 2024.

The largest trade he's ever made was exercising 283,390 units of Precision BioSciences stock on 2 November 2023 worth over $2,975,595. On average, Mr trades about 27,805 units every 40 days since 2020. As of 1 May 2024 he still owns at least 15,298 units of Precision BioSciences stock.

You can see the complete history of Mr Amoroso stock trades at the bottom of the page.





Mr. Michael Amoroso biography

Michael Amoroso is the Pres, CEO & Director at Precision BioSciences.

What is the salary of Mr Amoroso?

As the Pres and CEO & Director of Precision BioSciences, the total compensation of Mr Amoroso at Precision BioSciences is $876,238. There are no executives at Precision BioSciences getting paid more.



How old is Mr Amoroso?

Mr Amoroso is 42, he's been the Pres and CEO & Director of Precision BioSciences since . There are 6 older and 1 younger executives at Precision BioSciences. The oldest executive at Precision BioSciences, Inc. is Dr. David S. Thomson Ph.D., 59, who is the Chief Operating Officer.

What's Mr Amoroso's mailing address?

Michael's mailing address filed with the SEC is 6555 CARNEGIE AVE,, 4TH FLOOR, CLEVELAND, OH, 44103.

Insiders trading at Precision BioSciences

Over the last 5 years, insiders at Precision BioSciences have traded over $352,500 worth of Precision BioSciences stock and bought 224,670 units worth $1,909,002 . The most active insiders traders include Raymond F Schinazi, Llc Fmr, and Michael Amoroso. On average, Precision BioSciences executives and independent directors trade stock every 22 days with the average trade being worth of $357,735. The most recent stock trade was executed by Dario Scimeca on 7 June 2024, trading 301 units of DTIL stock currently worth $3,161.



What does Precision BioSciences do?

Precision BioSciences, Inc., a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which a specific type of immune cell, called a T cell, is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.



What does Precision BioSciences's logo look like?

Precision BioSciences, Inc. logo

Complete history of Mr Amoroso stock trades at Abeona Therapeutics Inc and Precision BioSciences

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
1 May 2024 Michael Amoroso
President and CEO
Option 3,417 $10.48 $35,810
1 May 2024
15,298
20 Jan 2024 Michael Amoroso
President and CEO
Option 266,720 $0.38 $101,354
20 Jan 2024
493,823
2 Nov 2023 Michael Amoroso
President and CEO
Option 283,390 $0.40 $113,356
2 Nov 2023
352,128
21 Mar 2023 Michael Amoroso
President and CEO
Option 102,535 $0.85 $87,155
21 Mar 2023
115,737
15 Oct 2022 Michael Amoroso
President and CEO
Option 24,208 $1.33 $32,197
15 Oct 2022
24,208
27 Sep 2023 Michael Amoroso
Director
Sale 5,508 $3.91 $21,536
27 Sep 2023
108,957
20 Sep 2023 Michael Amoroso
Director
Sale 327 $3.90 $1,275
20 Sep 2023
114,465
20 Jun 2023 Michael Amoroso
Director
Sale 338 $4.45 $1,504
20 Jun 2023
114,792
20 Mar 2023 Michael Amoroso
Director
Sale 268 $2.33 $624
20 Mar 2023
56,441
3 Mar 2023 Michael Amoroso
Director
Sale 1,002 $2.38 $2,385
3 Mar 2023
56,709
30 Sep 2021 Michael Amoroso
Director
Sale 45,409 $1.09 $49,496
30 Sep 2021
604,637
31 Mar 2021 Michael Amoroso
Director
Sale 45,409 $1.87 $84,915
31 Mar 2021
650,046


Precision BioSciences executives and stock owners

Precision BioSciences executives and other stock owners filed with the SEC include: